Cash & Short-Term Investments

$115.20M

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$149.60Mperiod endingDec 31, 2025

MYGN FY Cash & Short-Term Investments ($13.20M → $149.60M)

Annual Cash & Short-Term Investments

High-resolution chart · PNG

MYGN cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc Cash & Short-Term Investments — Annual fiscal periods (USD)
Period ending	Cash & Short-Term Investments (USD)
Dec 31, 2025	149,600,000
Dec 31, 2024	102,400,000
Dec 31, 2023	140,900,000
Dec 31, 2022	114,900,000
Dec 31, 2021	338,800,000
Dec 31, 2020	150,700,000
Jun 30, 2020	217,800,000
Jun 30, 2019	136,900,000
Jun 30, 2018	180,600,000
Jun 30, 2017	150,700,000
Jun 30, 2016	159,000,000
Jun 30, 2015	144,800,000
Jun 30, 2014	186,400,000
Jun 30, 2013	372,316,000
Jun 30, 2012	340,532,000
Jun 30, 2011	346,457,000
Jun 30, 2010	403,228,000
Jun 30, 2009	316,855,000
Jun 30, 2008	328,728,000
Jun 30, 2007	214,111,000
Jun 30, 2006	227,744,000
Jun 30, 2005	113,843,000
Jun 30, 2004	115,366,000
Jun 30, 2003	72,775,000
Jun 30, 2002	73,074,899
Jun 30, 2001	127,219,298
Jun 30, 2000	80,501,691
Jun 30, 1999	9,900,000
Jun 30, 1998	14,600,000
Jun 30, 1997	15,700,000
Jun 30, 1996	13,200,000